 <h1>Vumerity Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>diroximel fumarate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about diroximel fumarate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Vumerity.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to diroximel fumarate: oral capsule delayed release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, diroximel fumarate (the active ingredient contained in Vumerity) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking diroximel fumarate:</p><p>
<i>Less common</i>
</p><ul>
<li>Cough or hoarseness</li>
<li>fever or chills</li>
<li>lower back or side pain</li>
<li>painful or difficult urination</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Back pain</li>
<li>bloating of the stomach</li>
<li>blurred vision</li>
<li>confusion</li>
<li>dark urine</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>fast heartbeat</li>
<li>headache</li>
<li>hives, itching, or skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>light-colored stools</li>
<li>nausea</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>seizures</li>
<li>stomach pain</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of diroximel fumarate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>feeling of warmth</li>
<li>redness of the face, neck, arms and occasionally, upper chest </li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>heartburn</li>
<li>indigestion</li>
<li>stomach discomfort or upset</li>
</ul><p>
<!-- end oral capsule delayed release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diroximel fumarate: oral delayed release capsule</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Progressive multifocal leukoencephalopathy (PML), serious infections<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Albumin urine present<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Aspartate aminotransferase increased</p>
<p><b>Frequency not reported</b>: Liver injury</p>
<p><b>Postmarketing reports</b>: Liver function abnormalities (elevations in transaminases 3 times ULN or greater with concomitant elevations in total bilirubin greater than 2 times ULN)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (40%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, erythema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (18%), diarrhea (14%), nausea (12%)</p>
<p><b>Common</b> (1% to 10%): Vomiting<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How do Vumerity and Tecfidera compare for multiple sclerosis (MS)?</li>
<li>How long does it take for it to work?</li>
<li>Vumerity vs Mayzent - what's the difference?</li>
<li>How does it work?</li>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Vumerity (diroximel fumarate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Vumerity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to diroximel fumarate: oral delayed release capsule</i></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphopenia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylaxis, angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Progressive multifocal leukoencephalopathy (PML), serious infections<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Albumin urine present<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Aspartate aminotransferase increased</p><p><b>Frequency not reported</b>: Liver injury</p><p><b>Postmarketing reports</b>: Liver function abnormalities (elevations in transaminases 3 times ULN or greater with concomitant elevations in total bilirubin greater than 2 times ULN)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (40%)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, erythema<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (18%), diarrhea (14%), nausea (12%)</p><p><b>Common</b> (1% to 10%): Vomiting<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Vumerity (diroximel fumarate)." Alkermes, Inc, Cambridge, MA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How do Vumerity and Tecfidera compare for multiple sclerosis (MS)?</li>
<li>How long does it take for it to work?</li>
<li>Vumerity vs Mayzent - what's the difference?</li>
<li>How does it work?</li>
<li>What are the new drugs used for multiple sclerosis (MS)?</li>
</ul><h2>More about Vumerity (diroximel fumarate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: selective immunosuppressants</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Vumerity &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>